Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company. Accuray develops, manufactures and sells personalized, best-in-class treatment solutions that revolve around the patient. Accuray’s game-changing technologies – the CyberKnife System and TomoTherapy Systems – set the standard of care with the aim of helping patients live longer, better lives. To date, more than 200,000 patients worldwide have been treated using the company’s technologies and more than 550 systems have been installed in leading hospitals around the world. On November 4, 2008, the Company completed the acquisition of Chengdu Twin Peak Accelerator Technology Inc.
The TomoTherapy treatment systems contain a linear accelerator, which is a device that generates external beam radiation that is used both to capture images that accurately depict the size, shape, and density of the tumor, and to deliver therapeutic radiation to ed targets in a helical, or spiral, delivery pattern 360 degrees around the body.

Accuray Incorporated （纳斯达克股票代码：ARAY）专业从事先进的放射治疗解决方案的开发和销售，其解决方案可用于治疗各种从最普通到最复杂的癌症。Accuray的Cyberknife和TomoTherapy平台采用滑环机架，将集成CT成像与适形放射治疗相结合，快速精确地提供尖端的放射治疗，同时降低周围健康组识受辐射的程度。Accuray和北美、欧洲、中东以及亚太地区的医院和癌症治疗中心有着密切的合作关系。在2008年11月4日，宣布全资收购成都双峰加速器技术有限公司。
TomoTherapy的Hi-Art全方位治疗系统装配了医用直线加速器。 该加速器可以产生外部的辐射束，有助于生成对肿瘤大小，形状，位置及密度准确定位的图像，同时直线加速器能够对身体需要治疗部位发射螺旋状治疗射线，以便对患处进行360度全方位治疗。
自从Accuray收购中国这家高科技民营企业后器，改变直线加速管供货来源单一的局面，而直线加速管又是公司生产的放疗设备Hi∙Art的最重要的部件，同时，这项并购还能提高公司在支线加速器设计和制造上的竞争能力，有助于改善设备的稳定性，并有助于提升利润空间。
Welcome to visit our website http://www.accuray.com/ for more information.
请访问公司网站，了解更多信息。